Full Breakdown
SandboxAQ Embeds Physics-Grounded AI Models into Anthropic’s Claude, Opening Conversational Drug Discovery for India
5/21/2026, 4:42:37 AM
Integration of Quantitative AI into Claude
SandboxAQ announced that its Large Quantitative Models (LQMs)—physics-grounded AI systems capable of quantum-chemistry calculations, molecular-dynamics simulations and microkinetics—are now accessible through Anthropic’s Claude chatbot. Using the Model Context Protocol, a frontier language model is linked to a frontier quantitative model, allowing users to issue plain-English prompts that trigger complex simulations without provisioning dedicated computing infrastructure.
Background: The Interface Bottleneck
Founded five years ago as an Alphabet spin-out, SandboxAQ has raised over $950 million and built a cybersecurity unit alongside its scientific-AI platform. While many AI startups focus on model accuracy, SandboxAQ argues that the primary barrier to adoption is the user interface. Its LQMs differ from standard large language models by being trained on real-world lab data and scientific equations, targeting the “quantitative economy” estimated at more than $50 trillion across biopharma, energy, finance and advanced materials.
Key Players and Indian Ecosystem
The partnership involves SandboxAQ, Anthropic (creator of Claude), and Indian stakeholders such as Bengaluru-based Peptris Technologies, which raised INR70 crore in Series A funding, and BioVaram, a deep-tech startup showcased at BioAsia 2026. The Indian Department of Pharmaceuticals organized an AI-driven drug-discovery webinar in April 2026, reflecting governmental interest in the technology.
Data & Scale
- SandboxAQ funding: > $950 million (including $900 million raised)
- Quantitative-economy size: $50 + trillion
- Indian AI-driven biotech funding: Peptris INR70 crore Series A; multiple startups active in drug discovery and regenerative medicine
- Regulatory framework: India’s Digital Personal Data Protection (DPDP) Act 2023 and Rules 2025 govern processing of genomic and patient data used to train AI models.
Official Statements & Responses
SandboxAQ’s release emphasizes that LQMs are “engineered for the quantitative economy” and that the Claude integration removes the need for specialized hardware. Nadia Harhen, General Manager of AI Simulation, highlighted that customers previously struggled with existing software and that the new conversational interface enables “frontier quantitative models” to be accessed “in natural language.” Anthropic’s documentation confirms that the models are being rolled out through the standard Claude chat interface.
Criticism, Regulatory Concerns, and Gaps
Analysts note that the LQMs are trained on global datasets and are not yet fine-tuned for India-specific chemistry, manufacturing conditions or demographic profiles. The DPDP Act adds a compliance layer, requiring explicit consent for repurposing personal genomic data, which could limit the breadth of data available for model training in India. These gaps suggest a need for localized model adaptation and robust data-governance practices.
Why It Matters for Indian Biotech
India’s large pool of scientific talent and its position as a hub for generic drug manufacturing could benefit from reduced computational barriers. By allowing researchers, students and founders to run quantum-chemistry simulations through a chatbot, the integration promises lower entry costs, faster hypothesis testing, and new educational approaches that shift from memorisation to interactive problem-solving.
Verbatim Quotes
- “Trained on real-world lab data and scientific equations, LQMs are AI models engineered for the quantitative economy, a $50+ trillion sector spanning biopharma, financial services, energy, and advanced materials,” — SandboxAQ press release
- “For the first time, we have a frontier [quantitative] model on a frontier LLM that someone can access in natural language,” — Nadia Harhen, General Manager of AI Simulation, SandboxAQ
- “Our customers come to us because they’ve tried all the other software out there, and the complexity of their problem is such that it didn’t work or didn’t yield positive results for them when that translation went to take place in the real world,” — Nadia Harhen, SandboxAQ
- “A: It lets you access Large Quantitative Models (LQMs) for drug discovery and materials science through natural language prompts inside Claude.” — SandboxAQ FAQ
What’s Next
SandboxAQ plans to expand the rollout of Claude-based access in the coming months, while Indian startups explore fine-tuning the models for local disease targets. Ongoing dialogues between industry groups and regulators aim to align AI-driven drug discovery with the DPDP framework, setting the stage for broader adoption across India’s biotech sector.
